Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 2,200 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.
How did MASI's recent EPS compare to expectations?
The most recent EPS for Masimo Corp is $1.08, not beating expectations of $1.46.
How did Masimo Corp MASI's revenue perform in the last quarter?
Masimo Corp revenue for the last quarter is $1.08
What is the revenue estimate for Masimo Corp?
According to 8 of Wall street analyst, the revenue estimate of Masimo Corp range from $419.92M to $386.02M
What's the earning quality score for Masimo Corp?
Masimo Corp has a earning quality score of B+/57.14419. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Masimo Corp report earnings?
Masimo Corp next earnings report is expected in 2026-08-03
What are Masimo Corp's expected earnings?
Masimo Corp expected earnings is $405.47M, according to wall-street analysts.
Did Masimo Corp beat earnings expectations?
Masimo Corp recent earnings of $403.6M does not beat expectations.